How should I choose a mouthwash? Which one should I use for periodontal disease?

How should I choose a mouthwash? Which one should I use for periodontal disease?

The 60-character direct answer

Mouthwash is an adjunct. It cannot replace toothbrushing or interdental cleaning, and it cannot replace mechanical treatment for periodontal disease [F1][F2]. Which bottle to use for periodontal disease only becomes a meaningful question once a dentist has made the diagnosis and the necessary treatment has been completed; only then does adjunctive antimicrobial use make sense [F5][F6].

Scope: This article is general health education based on international literature and does not concern any particular country's insurance or regulations. Rules on the sale and labelling of mouthwash, and on whether professional direction is required, differ from place to place; follow the notices published by your local competent authority and the product label. Consultations and medication decisions should be assessed by a dentist where you live.

This search is not one question, it is four

People who search for "how should I choose a mouthwash" are, in their own minds, trying to solve several completely different situations: wanting to prevent caries, red and bleeding gums, an existing diagnosis of periodontal disease, or the feeling of having bad breath. In the literature these four situations map onto different ingredients, different strengths of evidence, and even different orders of care. Mixing them into a single question is exactly what produces the unconditional answer "just buy this bottle".

This card names no brand, ranks nothing, makes no product recommendation, and will not tell you which bottle to buy. What follows is taken apart in the order "what the evidence says, what the trade-off is, who it is not suitable for", so that you can carry the question to your own dentist. The four-way split used in this section is this site's editorial framework for explanation, not a diagnostic tool [F30].

1. First, the key point: what mouthwash cannot replace

It cannot replace brushing and interdental cleaning

• Dental plaque is the primary cause of caries and periodontal disease, so mechanically disrupting and removing plaque every day is treated in the literature as the foundational work of oral health [F1].
• Brushing can clear supragingival plaque from the facial and the lingual/palatal surfaces of the teeth, but interdental areas usually need tools such as floss, interdental brushes, wood sticks, or oral irrigators before they can be reached at all [F1].
• A Cochrane systematic review that included 35 randomised controlled trials and 3,929 adults calculated that adding floss on top of brushing may reduce the gingival index at 1 month (standardised mean difference -0.58, 95% confidence interval -1.12 to -0.04; 8 trials, 585 participants), and likewise at 3 months and 6 months; the authors graded this evidence as low certainty [F1].
• Put another way: the antiplaque and antigingivitis mouthwash studies cited in this card all test its additional effect "on top of mechanical cleaning", not its use as a replacement for mechanical cleaning [F7][F8]. (Studies of the fluoride mouthwash category have a different purpose; see the section below.)

It cannot replace mechanical treatment for periodontal disease

• This is the sentence most easily buried by advertising copy: the consensus report of the 11th European Workshop on Periodontology, convened by the European Federation of Periodontology (EFP), states plainly that preventive measures are not sufficient to treat periodontitis; repeated and individualised oral-hygiene instruction, together with professional mechanical removal of plaque and calculus, are the important components of a prevention programme [F2].
• What can mechanical treatment achieve? A systematic review and meta-analysis of 72 articles, conducted by an expert panel of the American Dental Association (ADA) Council on Scientific Affairs, calculated that scaling and root planing (SRP) brings an average clinical attachment level improvement of about 0.5 mm (moderate certainty); once assorted adjunctive therapies are added to SRP, the additional improvement compared with SRP alone falls between 0.2 and 0.6 mm [F3].
• Note that "adjunctive therapy" here refers to systemic antibiotics, host-modulating drugs, locally delivered agents (for example a chlorhexidine chip placed into the periodontal pocket), and lasers [F3]. A network meta-analysis of 22 studies completed by a Taiwanese research team calculated that, for patients with residual pockets during supportive periodontal therapy, the chlorhexidine-chip group had a pocket-depth reduction of 0.65 mm (95% confidence interval 0.21 to 1.10) and the tetracycline-fibre group 0.64 mm (0.20 to 1.08), while the remaining adjunctive antimicrobials did not reach statistical significance compared with SRP alone; the authors concluded that these locally delivered antimicrobials bring a small additional improvement [F4].
• Reading those two passages together shows one thing: what brought additional improvement for residual pockets in the literature were the locally delivered preparations "placed into the pocket"; rinsing as a route of delivery was not within the comparison scope of that analysis [F4]. And within its stepwise treatment pathway, the EFP clinical guideline has one group of recommendations addressing supragingival and subgingival instrumentation, explicitly listing it as "with or without adjunctive therapies" [F5]. This passage is this site's editorial synthesis based on F3, F4, and F5 [F30].

2. How to read the ingredients: what has been studied for each of the four categories

First, a shared baseline: a systematic review of 70 studies commissioned by the EFP calculated that, compared with mechanical plaque control alone, adding an antimicrobial adjunct does bring statistically significant reductions in gingival index, bleeding percentage, and plaque index (gingival index standardised mean difference -1.268, 95% confidence interval -1.489 to -1.047, I² = 96.2%); within that, the mouthrinse formulation produced a larger reduction in plaque percentage than the toothpaste formulation (meta-regression coefficient 13.80%, 95% confidence interval 2.40% to 25.10%); at the same time the heterogeneity of that review was extremely high [F7]. Another systematic review, of 87 articles and 133 comparisons, found the same direction of result: formulations containing specific chemical plaque-control agents provide statistically significant improvements in the gingival, bleeding, and plaque indices, likewise accompanied by significant heterogeneity [F8].

"Statistically significant" does not mean "you will feel it", and it does not mean "you can skip a brushing" — as the chlorhexidine passage below shows, Cochrane went as far as labelling one statistically significant difference "not considered clinically relevant" [F11]. This sentence is this site's editorial reminder about the effect sizes above [F30]. The four categories are examined separately below.

Chlorhexidine (CHX)

The body of literature on this category is thick, and its costs are documented just as clearly.

• A Cochrane systematic review of 51 studies and 5,345 participants calculated that adding chlorhexidine mouthrinse for 4 to 6 weeks on top of mechanical oral hygiene reduced the gingival index (a 0 to 3 scale) by 0.21 compared with placebo, control, or no rinsing (95% confidence interval 0.11 to 0.31; 10 trials, 805 participants with on average mild gingival inflammation; high-quality evidence) [F9].
• The same review found a much larger effect size for plaque: at 4 to 6 weeks the standardised mean difference was 1.45 (95% confidence interval 1.00 to 1.90; 12 trials, 950 participants; high-quality evidence), representing a large reduction in plaque; a similarly large reduction was also present at 6 months [F10].
• But the authors wrote their conclusion on "gingivitis" very conservatively: that reduction of 0.21 was, in a population with on average mild gingival inflammation, "not considered clinically relevant"; and for people whose gingival index averages between 1.1 and 3 (moderate to severe inflammation), the evidence is insufficient to determine how much gingivitis chlorhexidine mouthrinse can reduce; beyond that, there is no evidence that any one concentration is more effective than another [F11].
• Cost one: staining. The same review recorded that extrinsic tooth staining increased substantially at 4 to 6 weeks among users of chlorhexidine mouthrinse (standardised mean difference 1.07, 95% confidence interval 0.80 to 1.34; 8 trials, 415 participants; moderate-quality evidence); the authors' concluding sentence states directly that "use for 4 weeks or longer causes extrinsic tooth staining" [F12].
• Cost two: other adverse reactions. The most frequently reported among the included studies were taste disturbance or alteration (11 studies), effects on the oral mucosa (including soreness, irritation, mild desquamation, and mucosal ulceration or erosion; 13 studies), and a general burning sensation or burning tongue (9 studies); findings on calculus formation were inconclusive [F13].
• In the population wearing fixed orthodontic appliances, a systematic review of 14 randomised controlled trials and 602 patients aged 11 to 35 recorded that the trials used CHX mouthrinse at 0.06%, 0.12%, or 0.2%; CHX rinsing did reduce plaque accumulation and gingival inflammation during orthodontic treatment, but some of the comparator mouthwashes in those trials were judged to be similarly effective [F14].

Reading the lines above together: the effect size of chlorhexidine on plaque is very clear in the literature, but it carries at the same time the costs of staining and of mucosal and taste effects, and on how the concentration, frequency of use, and duration of use should be set, Cochrane gives no "one size fits all" answer [F11][F12][F13]. This site therefore takes a conservative position: the concentration, frequency, and duration of this category of antimicrobial mouthrinse should be directed by a dentist according to the diagnosis, and unsupervised long-term self-use is not appropriate — because self-medicating with oral-care products without a diagnosis of the underlying disease has its limits [F6][F30].

⚠ Compliance reminder: This passage describes the efficacy and adverse reactions of a specific medicinal ingredient. It is health-education material, points to no brand or product, and does not constitute medication advice; human review is recommended.

Essential-oil combinations

• A meta-analysis reviewed all industry-sponsored clinical trials published between 1980 and 2012 that examined the antigingivitis and antiplaque effects of essential-oil-containing mouthrinse; 29 of the 32 met the inclusion criteria of "followed for 6 months or longer, randomised, observer-blind, placebo-controlled, and with individual site-level data". The result: mechanical cleaning plus essential-oil mouthrinse, compared with mechanical cleaning alone, gave whole-mouth mean percentage reductions in gingivitis and plaque of 16.0 (95% confidence interval 11.3 to 20.7) and 27.7 (22.4 to 32.9) respectively [F15]. The inclusion criterion of that analysis was itself "all industry-sponsored clinical trials", so the funding source has to be read together with the numbers [F15].
• Another meta-analysis and meta-regression, which included 16 studies out of 3,045 records, calculated that essential oils plus mechanical cleaning, compared with placebo plus mechanical cleaning, gave a weighted mean difference of -0.86 on the Quigley-Hein plaque index (95% confidence interval -1.05 to -0.66) and -0.52 on the modified gingival index (-0.67 to -0.37); at the same time the heterogeneity of that analysis was extremely high (I² above 95%), and the risk-of-bias quality of the included studies ranged from moderate to low [F16].

CPC (cetylpyridinium chloride)

• A systematic review and meta-analysis of 8 studies calculated that CPC mouthrinse used as an adjunct to brushing, compared with placebo, reduced the interproximal plaque index by 0.70 (95% confidence interval 0.57 to 0.83) and the gingival index by 0.38 (0.28 to 0.47); but the heterogeneity of both analyses was high (I² 89% and 98% respectively) [F17].
• The position discussed for this category in that review is that it compensates for the shortfall in interproximal plaque removal — note that "compensate" is not "replace"; the role of interdental cleaning tools has not been cancelled [F17][F1].

Fluoride mouthwash

The purpose of this category is completely different from the three above: what it targets is caries, not the gums.

• A Cochrane systematic review of 37 trials and 15,813 children and adolescents calculated that the pooled preventive fraction for decayed permanent tooth surfaces (D(M)FS) was 27% (95% confidence interval 23% to 30%, I² = 42%; moderate-quality evidence); the pooled preventive fraction for decayed permanent teeth (D(M)FT) was 23% (18% to 29%) [F18].
• The key condition: every trial included in that review measured "supervised" use in schools (2 of them additionally included home use); the authors also stated that information on adverse effects and acceptability in the included trials was limited, and that 28 of them were at high risk of bias [F18].
• The age boundary: the clinical recommendations issued by the expert panel of the American Dental Association (ADA) Council on Scientific Affairs for people at risk of caries restrict home-use 0.09% fluoride mouthrinse to ages 6 and above; for children under 6, that recommendation lists only 2.26% fluoride varnish [F19].
• Why the line is drawn at 6: a Cochrane systematic review of children under 6 pointed out that a possible adverse effect of topical fluoride is fluorosis caused by a young child swallowing too much fluoride (with the developing teeth affected); the authors concluded that a balance should be struck between the anti-caries benefit and the fluorosis risk [F20].

Herbal and plant-extract formulations

The "herbal / natural" claims that are common in search results sit like this in the literature:

• One systematic review found only 3 eligible randomised controlled trials among 206 articles; these studies reported that neem mouthrinse, used as an adjunct to brushing, was similarly effective to chlorhexidine mouthrinse in reducing plaque and gingival inflammation, but the authors judged the reporting quality, the evidence, and the methods of these studies to be generally flawed with unclear risk of bias, and stated explicitly that the current evidence on the clinical use of neem mouthrinse is insufficient and needs high-quality randomised controlled trials to strengthen it [F27].
• Another systematic review and meta-analysis of 7 randomised controlled trials compared triphala mouthrinse with chlorhexidine mouthrinse: the overall weighted mean difference was -0.29 for the gingival index (95% confidence interval -0.40 to -0.17) and -0.43 for the plaque index (-0.54 to -0.31), and the authors concluded that the two were clinically comparable; but the heterogeneity of both analyses was extremely high (I² 91.76% and 96.10% respectively) [F28].
• This card's position on this category is the same as that of the authors of these reviews: the evidence is not yet able to decide for you, and the sentence "comparable to chlorhexidine" cannot be read backwards as "therefore it can replace treatment" [F27][F28][F30].

3. The correct answer to "which bottle should I use for periodontal disease?"

This is the second question in this card's title, and it is the one where the cost of getting it wrong is high. The honest answer is not the name of a bottle; it is an order of steps.

• Step one, diagnosis. The EFP consensus report states that before a person is given professional preventive measures, an appropriate periodontal diagnosis is needed, and that diagnosis determines which category of preventive care is to be adopted [F2]. The introductory report of the same workshop named a public-health problem even more directly: self-medicating with oral-care products without a diagnosis of the underlying disease has its limits; the same report also called for the public to understand the importance of the fact that "gingival bleeding is an early sign of disease" [F6].
• Step two, mechanical treatment. The EFP S3-level clinical guideline for stage I to III periodontitis adopts a pre-established stepwise treatment pathway, adding different interventions step by step according to the stage of disease; among the recommendations on which that guideline reached consensus, one group addresses supragingival and subgingival instrumentation and explicitly lists it as "with or without adjunctive therapies" [F5]. In other words, in the wording of the guideline, adjunctive therapy is an add-on option to instrumentation, not a substitute for it [F5][F30].
• Step three, and only then, adjunctive antimicrobials. And even at this step, the effect sizes have to be read carefully: antimicrobial adjuncts bring statistically significant reductions on the two indicators of gingivitis and plaque [F7]; on the indicator of the periodontal pocket, what has a small additional effect is the locally delivered preparation placed into the pocket [F4].
• There is one more detail that is often skipped: the same EFP-commissioned systematic review recorded that the antimicrobial agents were similarly effective in the two populations of "plaque-induced gingivitis (in people with an intact periodontium)" and "people who have previously had periodontal treatment and still have gingival inflammation" [F7]. What that sentence establishes is that adjunctive antimicrobial use has been tested in both of these settings; as for "using it to replace the treatment that ought to be done", that was not within the scope of what these studies examined [F7][F30].

So if you are searching for "which bottle should I use for periodontal disease", the answer this card can give with literature behind it is: first let a dentist diagnose and stage the disease and complete the mechanical treatment that has to be done; which category of adjunct, for how long, and at what concentration are decided by the dentist according to your diagnosis and your recovery. Actual treatment approaches and outcomes vary from person to person and must be assessed by a dentist.

4. Risk factors and limitations: who it is not suitable for, and when to stop

• The known costs of chlorhexidine: extrinsic tooth staining (which occurs with use of 4 weeks or longer) [F12]; taste disturbance or alteration, oral mucosal soreness and irritation, mild desquamation, mucosal ulceration or erosion, and a burning sensation in the mouth or on the tongue [F13]; the evidence on calculus formation is inconclusive [F13].
• Allergy: reports of allergic reactions caused by chlorhexidine already exist in the literature, in the general population and in workers alike; one systematic literature review identified 14 cases of occupational chlorhexidine-induced allergy among occupationally exposed healthcare workers, and the clinical presentation in these cases was mostly mild with resolution of symptoms [F24]. The population in that review was occupationally exposed, and it cannot be extrapolated directly to ordinary mouthrinse users; that said, Cochrane also cautions in another review that most studies did not deliberately set out in their design to detect allergic reactions to mouthwash [F21]. If swelling, difficulty breathing, or similar reactions occur after use, stop using it and seek medical care.
• Alcohol-containing formulations: the conclusion of a systematic review of 8 studies with a total of 43,499 participants states that it is not possible to confirm mouthwash itself as an independent risk factor for head and neck cancer; but when it coexists with other carcinogenic risk factors, the risk does rise [F23]. Both halves of that sentence have to be read: there is no need to panic over it, but if you also smoke, chew betel nut, or drink heavily, an alcohol-containing formulation is a variable to discuss with your dentist.
• Children under 6: the lower age limit in the clinical recommendation for home-use fluoride mouthrinse is 6 years [F19]; the concern below 6 lies in swallowing excessive fluoride and the risk of fluorosis [F20].
• People with poor swallowing control: the whole body of efficacy evidence for fluoride mouthrinse was accumulated in a supervised use setting [F18]; people who cannot reliably spit it all out (including young children and some people with special needs) need a professional to assess whether it is suitable for them.
• A shared premise: every effect size cited in this card is a study-level group figure. It cannot be used to estimate your individual outcome, and it cannot replace clinical diagnosis.

5. Children and pregnancy

Children

• The threshold to clear first is age, not flavour. In the clinical recommendation, home-use fluoride mouthrinse applies to ages 6 and above (that recommendation is addressed to people at risk of caries); for those under 6, what the recommendation lists is professionally applied fluoride varnish [F19].
• Supervision matters more than the brand. The anti-caries evidence for fluoride mouthrinse (a 27% preventive fraction for decayed permanent tooth surfaces) all comes from supervised use in schools (2 of the trials additionally included home use) [F18]; when it is used at home without supervision the size of the effect is less clear, and the same Cochrane review has already noted this [F18].
• The direction of the risk has to be stated clearly: it is not that "mouthwash is toxic", it is that a young child swallowing too much fluoride affects the developing teeth (fluorosis), which is why a balance has to be struck between the anti-caries benefit and the fluorosis risk [F20].

Pregnancy

• There are data behind the worsening of gum condition during pregnancy: a systematic review and meta-analysis of 20 studies calculated that the pooled prevalence of periodontitis during pregnancy is 40% (95% confidence interval 0.15 to 1.00), and that the prevalence of positive bleeding on probing and the prevalence of pocket depth ≥4 mm both rose progressively across the pregnancy; that review also stated that heterogeneity between the included studies was high [F25]. The background section of another Cochrane review likewise states that gum conditions tend to deteriorate during pregnancy [F26].
• But on the question of whether periodontal treatment during pregnancy can improve obstetric outcomes, the evidence is not as settled as people assume: the conclusion of a Cochrane review of 15 randomised controlled trials and 7,161 participants states that it is unclear whether periodontal treatment during pregnancy affects preterm birth (low-quality evidence); there is low-quality evidence suggesting it may reduce low birth weight (below 2500 g), but the authors had limited confidence in this effect estimate, and all of the included studies were rated at high risk of bias [F26].
• This card's position on pregnancy is therefore conservative: if bleeding and swollen gums appear during pregnancy, what should be done is to have a dentist assess it, not to pick a bottle of mouthwash and solve it yourself. Whether to use one, which category to use, and for how long must be assessed by a dentist (and, where the situation calls for it, jointly with an obstetrician). Actual treatment approaches and outcomes vary from person to person.

6. Halitosis and after an extraction: two uses that are often searched together

Halitosis: the level of evidence is far lower than you would think

• A Cochrane systematic review of 44 trials and 1,809 participants compared interventions including mechanical cleaning, chewing gum, systemic deodorising agents, topical preparations, toothpastes, mouthwashes, and combinations of these. The authors' overall conclusion states that the level of evidence supporting the effectiveness of these interventions is low to very low, and that no conclusion whatsoever can be drawn about the superiority of any one intervention or concentration [F22].
• Specifically for mouthwash: for mouthrinse containing chlorhexidine and zinc acetate compared with placebo mouthrinse, the evidence on the dentist-rated organoleptic test score was extremely uncertain (mean difference -0.20, 95% confidence interval -0.58 to 0.18; 1 trial, 44 participants; very-low-certainty evidence) [F22].
• So if you are searching for a mouthwash because of bad breath: the literature at present cannot give an answer to "which bottle works". That review also excluded halitosis caused by systemic disease as well as masking interventions [F22] — finding the cause first is more meaningful than picking a bottle first.

After an extraction: one of the few uses where the evidence is relatively clear

• A Cochrane systematic review of 49 trials and 6,771 participants calculated that, compared with placebo, rinsing with chlorhexidine mouthrinse (at 0.12% and 0.2% concentrations) before the extraction and for 24 hours after it substantially lowers the risk of developing dry socket (odds ratio 0.38, 95% confidence interval 0.25 to 0.58; 6 trials, 1,547 participants; moderate-certainty evidence) [F21].
• The same review also recorded the costs: some evidence indicates that 0.12% and 0.2% chlorhexidine mouthrinses are associated with minor adverse reactions (taste alteration, tooth staining, stomatitis) [F21].
• Note the scope of this line: among the studies included in that review, all but 5 had participants who were having third molars extracted, and most were performed by oral surgeons [F21]. This is a use "during a clinician-directed period, in a specific setting", not a reason for everyday maintenance; whether to use it, when to start, and for how long must be individually assessed by the dentist performing the extraction according to your wound condition and contraindications [F21][F30]. For the healing rhythm of an extraction wound, see the internal citation chain at the end of this article.

7. Checklist before your appointment (7 questions)

1. Which situation am I actually in: just wanting to prevent caries, gums that bleed, an existing diagnosis of periodontal disease, or the feeling that I have bad breath?
2. Have my gums ever been formally examined (probing depth, bleeding points)? How did the dentist determine my stage?
3. If I need an adjunctive antimicrobial rinse, which ingredient category is it, at what concentration, how many times a day, and for how long is it expected to be used? How is it to be reviewed once that period ends?
4. Could the way I use it cause tooth staining? If staining has already occurred, how should it be handled, and do I need a follow-up visit for it?
5. In my current brushing and interdental cleaning, which part does the dentist think is not being done well enough? Is there an interdental cleaning tool better suited to me?
6. Am I (or is my child) suitable for fluoride mouthrinse? Do the conditions on age and swallowing control apply?
7. Am I pregnant, allergic to disinfectant ingredients, experiencing dry mouth, undergoing orthodontic treatment, or recently operated on in the mouth? Would any of these change the advice?

How to find a clinic that provides this service

This site lists no clinics and does not recommend, rate or compare any medical institution.

To find a clinic that provides this service, use the following official lookup channels yourself —

they are maintained by the competent authorities and are more current than any list:

>

- The Ministry of Health and Welfare's medical-institution lookup: search by city or county,

township and specialty (dentistry) for institutions that have completed practice registration.

The results show the institution's name, address and registered specialty. This is the first place

to confirm whether a clinic is lawfully registered.

- The National Health Insurance Administration's contracted-institution lookup: check whether a

clinic is under contract with National Health Insurance. This determines which items are covered

and which are self-paid, and therefore what kind of fee explanation you will be given.

>

Both systems are on the respective authorities' official websites; searching for the

medical-institution lookup or the contracted-institution lookup will find them. This site does not

reproduce the URLs, because they change; use whichever entry point the authority currently publishes.

>

In an emergency, do not spend time looking up lists. If your breathing, swallowing or speech is

affected, or swelling is spreading, go to the nearest emergency department.

Chinese labels to look for on the official pages

These official systems, datasets and files are published in Chinese only. The English names above are this site's renderings; on the page itself you will see the following strings, so search for these:

>

- 「醫事機構查詢」

- 「特約醫事機構查詢」

- 「特約院所查詢」

Compliance note

This is health education under Article 87 of Taiwan's Medical Care Act, not medical advertising. It does not recommend a particular clinic or recommend, compare, or endorse any mouthwash brand. Periodontal treatment and antimicrobial mouthrinses have risks and contraindications, including tooth staining, taste change, oral-mucosal irritation, and allergic reactions. Actual treatment and outcomes vary by person and require a dentist's assessment. The effect estimates and prevalence figures cited here are study-level group figures, cannot predict individual outcomes, and cannot replace clinical diagnosis. This card lists no product name, price, or purchase channel.

Every clinical statement in this article is mapped line by line to its cited source (see the sources and evidence chain below). It has not been clinically reviewed by a licensed practitioner. This is health information, not individual advice; assessment by a clinician is required.